Recent onset atrial fibrillation: baseline data from Thai subset of RECORD AF study

The RECORD AF study is the first worldwide, prospective, observational 1-year longitudinal survey of real-life management of patients with recently diagnosed atrial fibrillation (AF). The authors present here the baseline data of Thai subset of the study. The study enrolled consecutive patients of a...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Journal of the Medical Association of Thailand Ročník 97 Suppl 3; s. S115
Hlavní autori: Sriratanasathavorn, Charn, Pumprueg, Satchana, Boonyapisit, Warangkna
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: Thailand 01.03.2014
Predmet:
Aged
Antihypertensive Agents - therapeutic use
Atrial Fibrillation - complications
Atrial Fibrillation - epidemiology
Atrial Fibrillation - physiopathology
Atrial Fibrillation - therapy
Female
Heart Conduction System - physiopathology
Heart Rate - physiology
Humans
Hypertension - complications
Hypertension - drug therapy
Male
Middle Aged
Observational Studies as Topic
Thailand - epidemiology
Thailand
ISSN:0125-2208
On-line prístup:Zistit podrobnosti o prístupe
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:The RECORD AF study is the first worldwide, prospective, observational 1-year longitudinal survey of real-life management of patients with recently diagnosed atrial fibrillation (AF). The authors present here the baseline data of Thai subset of the study. The study enrolled consecutive patients of age > or = 18 years, presenting with and treated for AF (< or = 1 year from diagnosis), visiting office- or hospital-based cardiologists. The main primary objectives were to assess therapeutic success and clinical outcomes in rhythm- and rate-control strategies. Of 209 patients recruited between July and December 2007, 200 were eligible for evaluation (mean age: 62.8 years, SD 12.4; 51% males). Hypertension (49%) and dyslipidemia (36%) were the most common underlying cardiovascular diseases (CVDs). Thirty-six point nine percent of patients were at high risk of stroke (CHADS, score > or = 2). In the previous year 93 (52%) patients were diagnosed with paroxysmal AF and 86 (48%) patients with persistent AF. Rate-control was the main treatment strategy used in 151 (75.50%) of the patients, and was more frequently used in persistent AF (94.20%) than paroxysmal AF (61.3%). The most frequent medication used for rhythm-control strategy was amiodarone (83.7%) and, for rate-control strategy, it was beta-blockers (57%). For antithrombotic medication, antiplatelet agents were used in 92 (46%) patients and oral anticoagulation in 86 (43%) patients. For Thai patients with AF, hypertension and dyslipidemia were the most common underlying CVDs, and rate control was the preferred treatment strategy. The prospective 1-year data will provide insights on current AF treatment strategies.
Bibliografia:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0125-2208